In this issue:
- What happens if the US engineers a near monopoly on the supply of COVID-19 medicines and vaccines
- Why are governments encouraging the airline behemoths?
- Has the UK suddenly become the most aggressive of competition authorities
- The EU continues to target big tech
- 80,000 post-COVID complaints to the CMA – 7,000 per day
- Small banks consistently beat big banks on loans
- Twitter vs Trump